Profiel
Tsvetelina Pencheva Hoang formerly worked at Bellicum Pharmaceuticals, Inc., as Director-Translational Research from 2015 to 2018, The Phi Beta Kappa Society, as Member, and Marker Therapeutics, Inc., as Vice President-Research & Development from 2018 to 2024.
Dr. Hoang received her doctorate degree from The Johns Hopkins University and undergraduate degree and graduate degree from Yale University.
Eerdere bekende functies van Tsvetelina Hoang
| Bedrijven | Functie | Einde |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2024 |
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-07-2018 |
The Phi Beta Kappa Society
The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services Operates as a organisation for liberal arts and science education | Corporate Officer/Principal | - |
Opleiding van Tsvetelina Hoang
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Marker Therapeutics, Inc.
Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Phi Beta Kappa Society
The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services Operates as a organisation for liberal arts and science education | Commercial Services |
















